title: Regenerative medicine in diabetes.
abstract: Diabetes is a common multisystem disease that results in hyperglycemia due to a relative or absolute insulin deficiency. Improved glycemic control decreases the risk of development and progression of microvascular and, to a lesser extent, macrovascular complications and prevents symptomatic hyperglycemia. However, complex treatment regimens aimed at improving glycemic control are associated with an increased incidence of hypoglycemia. On paper at least, cellular therapies arising from reprogramed stem cells or other somatic cell types would provide ideal therapy for diabetes and the prevention of its complications. This hypothesis has led to intensive efforts to grow β cells from various sources. In this review, we provide an overview of β-cell development as well as the efforts reported to date in terms of cellular therapy for diabetes. Engineering β-cell replacement therapy requires an understanding of how β cells respond to other metabolites such as amino acids, free fatty acids, and ketones. Indeed, efforts thus far have been characterized by an inability of cellular replacement products to adequately respond to metabolites that normally couple the metabolic state to β-cell function and insulin secretion. Efforts to date intended to capitalize on current knowledge of islet cell development and stimulus-secretion coupling of the β cell are encouraging but as yet of little clinical relevance.
authors.affiliation: Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
authors.forename: Aleksey
authors.initials: A
authors.lastname: Matveyenko
authors.affiliation: Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN. Electronic address: vella.adrian@mayo.edu.
authors.forename: Adrian
authors.initials: A
authors.lastname: Vella
mesh_terms: D060846:Cell Engineering; D003920:Diabetes Mellitus / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D050417:Insulin-Secreting Cells / Q000502:physiology*; D044968:Regenerative Medicine
references.citation: N Engl J Med. 2013 Jul 25;369(4):362-72
references.pmid: 23883381
references.citation: Nature. 2008 Oct 2;455(7213):627-32
references.pmid: 18754011
references.citation: Diabetes. 2010 Jun;59(6):1285-91
references.pmid: 20508222
references.citation: Ann N Y Acad Sci. 2014 Apr;1311:124-37
references.pmid: 24611778
references.citation: Diabetes. 2014 May;63(5):1433-44
references.pmid: 24757193
references.citation: Diabetes. 2014 Mar;63(3):819-31
references.pmid: 24556859
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1607-11
references.pmid: 10677506
references.citation: Development. 2011 Mar;138(5):861-71
references.pmid: 21270052
references.citation: Nat Biotechnol. 2011 Aug;29(8):750-6
references.pmid: 21804561
references.citation: Genes Dev. 2011 Aug 15;25(16):1680-5
references.pmid: 21852533
references.citation: Science. 1998 Nov 6;282(5391):1145-7
references.pmid: 9804556
references.citation: Nat Biotechnol. 2014 Nov;32(11):1121-33
references.pmid: 25211370
references.citation: Nature. 2007 Feb 22;445(7130):886-91
references.pmid: 17259975
references.citation: Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):471-7
references.pmid: 20473152
references.citation: Diabetologia. 2012 Feb;55(2):358-71
references.pmid: 22075915
references.citation: Nat Biotechnol. 2000 Apr;18(4):399-404
references.pmid: 10748519
references.citation: Diabetes Care. 2006 Mar;29(3):717-8
references.pmid: 16505537
references.citation: Diabetes. 2012 May;61(5):969-75
references.pmid: 22517647
references.citation: Nat Genet. 1999 Nov;23(3):323-8
references.pmid: 10545951
references.citation: Medicine (Abingdon). 2010 Nov 1;38(11):597-601
references.pmid: 21151710
references.citation: Cell. 2014 Oct 9;159(2):428-39
references.pmid: 25303535
references.citation: Nat Biotechnol. 2011 Mar;29(3):267-72
references.pmid: 21358635
references.citation: J Biol Chem. 2008 Nov 14;283(46):31601-7
references.pmid: 18782754
references.citation: Nat Genet. 2012 Apr;44(4):406-12, S1
references.pmid: 22406641
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2334-9
references.pmid: 16461897
references.citation: Nat Genet. 1997 Jan;15(1):106-10
references.pmid: 8988180
references.citation: Diabetes. 2003 Jan;52(1):102-10
references.pmid: 12502499
references.citation: Gastroenterology. 2009 Apr;136(4):1225-33
references.pmid: 19249393
references.citation: Mol Ther. 2013 Jan;21(1):228-39
references.pmid: 23183535
references.citation: Diabetes. 2012 Sep;61(9):2205-13
references.pmid: 22751699
references.citation: Nat Biotechnol. 2008 Apr;26(4):443-52
references.pmid: 18288110
references.citation: Stem Cells Transl Med. 2012 Jun;1(6):451-61
references.pmid: 23197849
references.citation: Mol Ther. 2007 Feb;15(2):255-63
references.pmid: 17235302
references.citation: Pediatr Diabetes. 2014 Mar;15(2):127-34
references.pmid: 23992543
references.citation: Gene Ther. 2011 Mar;18(3):283-93
references.pmid: 21048796
references.citation: Cell Metab. 2013 Aug 6;18(2):162-85
references.pmid: 23791483
references.citation: Mech Dev. 2000 Mar 15;92(1):47-54
references.pmid: 10704887
references.citation: Diabetes. 2012 Aug;61(8):2016-29
references.pmid: 22740171
references.citation: Stem Cells Transl Med. 2012 Jan;1(1):59-63
references.pmid: 23197641
references.citation: Cell. 2007 Nov 30;131(5):861-72
references.pmid: 18035408
references.citation: Semin Cell Dev Biol. 2012 Aug;23(6):673-84
references.pmid: 22728667
references.citation: Diabetes. 2014 Apr;63(4):1203-13
references.pmid: 24651807
references.citation: Pancreas. 2008 Jul;37(1):75-84
references.pmid: 18580448
references.citation: Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E713-20
references.pmid: 20587750
references.citation: Stem Cells Transl Med. 2014 May;3(5):653-61
references.pmid: 24646490
references.citation: Nature. 1984 May 17-23;309(5965):255-6
references.pmid: 6717601
references.citation: Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3038-43
references.pmid: 24516164